World's top Pharmaceuticals stocks
Manufacturers and marketers of generic and specialty drugs, as well as researchers and developers of new drugs, medical products and procedures.
Name | Market Cap | Price to Earnings TTM | Dividend Yield % TTM |
---|---|---|---|
LLYEli Lilly and Co | $714.63bn | 74.66 | 0.6% |
NOVO BNovo Nordisk A/S | DKK3.92tn | 46.33 | 1.07% |
JNJ WDJohnson & Johnson | $397.54bn | 20.6 | 2.81% |
JNJJohnson & Johnson | $355.49bn | 17.7 | 3.19% |
MRKMerck & Co | $318.50bn | 91.9 | 2.35% |
ABBVAbbvie | $287.34bn | 35.72 | 3.65% |
AZNAstraZeneca | £171.52bn | 40.41 | 2.11% |
ROGRoche Holding AG | CH₣179.38bn | 12.5 | 4.27% |
RORoche Holding AG | CH₣179.38bn | 13.44 | 3.97% |
NOVNNovartis AG | CH₣175.99bn | 17.28 | 4.16% |
PFEPfizer | $146.43bn | 8.07 | 6.34% |
AMGNAmgen | $143.24bn | 20.9 | 3.19% |
SANSanofi SA | €108.20bn | 16.37 | 4.35% |
CELG RTBristol-Myers Squibb Co | $97.85bn | 0.01 | 4145.45% |
BMYBristol-Myers Squibb Co | $97.85bn | 12.88 | 4.72% |
CSLCSL | AU$136.09bn | 34.77 | 1.39% |
GILDGilead Sciences | $84.88bn | 11.74 | 4.41% |
GSKGSK | £68.12bn | 11.71 | 3.53% |
MRKMerck KGaA | €66.78bn | 20.03 | 1.43% |
MCKMcKesson | $68.73bn | 23.24 | 0.43% |